Eikon Therapeutics, Inc. Common Stock (NASDAQ: EIKN) — Healthcare · Share Price, Chart & Market Data
About: Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs using a platform that permits precise characterization of protein interactions in living cells. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.33 (-3.42%)
EIKNEikon Therapeutics, Inc. Common Stock
Loading watchlist status…
Trade EIKN now
Eikon Therapeutics, Inc. Common Stock share price
EIKN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 2:48 pm GMT+0
EIKN price performance
-20.571%
5D
-4.944%
1M
-37.833%
YTD
-37.833%
1Y
EIKN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 2:48 pm GMT+0
EIKN details
EIKN Market Signals